1488, Ideal Eyes
Payments companies reported to CMS as associated with 1488, Ideal Eyes. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with 1488, Ideal Eyes, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with 1488, Ideal Eyes
These are the largest totals companies reported as associated with 1488, Ideal Eyes. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| Alexander Coon | Baltimore, MD | Neurological Surgery | $18,071.42 |
| Ajay Wakhloo | Worcester, MA | Diagnostic Radiology | $12,682.73 |
| Geoffrey Colby | Los Angeles, CA | Neurological Surgery | $8,953.13 |
| Li-Mei Lin | Tucson, AZ | Neurological Surgery | $5,320.33 |
| Narlin Beaty | Tallahassee, FL | Neurological Surgery | $4,483.83 |
| Kazim Narsinh | San Diego, CA | Vascular & Interventional Radiology | $3,455.51 |
| Italo Linfante | Miami, FL | Neuroradiology | $3,094.17 |
| Santiago Ortega Gutierrez | Iowa City, IA | Vascular & Interventional Radiology | $2,560.77 |
| Justin Mascitelli | San Antonio, TX | Neurological Surgery | $2,228.90 |
| Adam Polifka | Jacksonville, FL | Neurological Surgery | $2,112.75 |
Prescribed 1488, Ideal Eyes?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.